| Value | ₹1.21 Cr |
|---|---|
| Execution period | Within 180 days from the execution of Energy Supply Agreement and Share Subscription and Shareholders Agreement |
BSE filing, NSE: ULTRACEMCO. Summary written from the filing by ALFA Finder's alert engine.
UltraTech Cement Ltd: key numbers
- Share price
- ₹11,175.00
- Market cap
- ₹3,29,304 Cr
- Revenue (annual)
- ₹88,512 Cr
- Net profit (annual)
- ₹8,166 Cr
- P/E (TTM)
- 37.4×Sector 32.4×
- Promoter holding
- 58.48%-0.85% QoQ
- FII holding
- 12.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UltraTech Cement Ltd
All →UltraTech Cement Employee Stock Options
UltraTech Cement granted 3,536 stock options, including 3,220 Options and 316 PSUs, under its 2022 Employee Stock Option and Performance Stock Unit Scheme.
UltraTech Cement Price Movement Clarification
UltraTech Cement clarified that the recent material price movement in its shares is market-driven, confirming no undisclosed information or impending announcements triggered the movement.
UltraTech Cement Debt & Borrowing: ₹460.5 Cr
UltraTech Cement approved a corporate guarantee of up to USD 55 million (approx. ₹460.5 Crore) for UHG Holdings IFSC Private Limited to support its business operations.
- Value
- ₹460.5 Cr
UltraTech Cement Investor Presentation: Key Takeaways
UltraTech reports robust Q2FY27 performance with consolidated revenue of Rs. 23,024 Cr (+18.9% YoY) and PAT of Rs. 1,501 Cr (+21.3% YoY). The company focus remains on aggressive capacity expansion and cost control.
UltraTech Cement Debt & Borrowing: ₹522.5 Cr
UltraTech Cement's board approved a USD 55 mn (₹522.5 Cr) corporate guarantee for associate UHG Holdings IFSC. The contingent liability supports UHG Holdings' business loan.
- Value
- ₹522.5 Cr
UltraTech Cement Management Change
UltrTech Cement's Vice Chairman K.K. Maheshwari steps down w.e.f. January 2027. MD K.C. Jhanwar re-designated as Non-Executive Vice Chairman after his MD term expires.
Other acquisition announcements
All →Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr
Krishna Institute of Medical Sciences Acquisition Worth ₹79.5 Cr
KIMS Ltd acquired a 51% stake in Sarvottam Health Care Private Limited for up to ₹79.50 Crore, aiming to expand its healthcare operations in Kakinada.
- Value
- ₹79.50 Cr
Meesho Acquisition Worth ₹50 Cr
Meesho approved up to Rs.50 Crore further investment in Retail Pulse Labs, payable in tranches. It follows the Kirana Club acquisition, making RPLPL a step-down subsidiary.
- Value
- ₹50.00 Cr
- Execution
- Within 1 year from the closing of the first tranche of the original acquisition
Meesho Acquisition Worth ₹18.74 Cr
Meesho will acquire a further stake in Retail Pulse Labs for ₹18.74 Crore cash. The step-down deal depends on completing the first Kirana Club tranche.
- Value
- ₹18.74 Cr
Meesho Acquisition Worth ₹6.17 Cr
Meesho will acquire 100% of Singapore-based Kirana Club in cash, up to USD 6.5 lakh in tranches. The target runs a digital platform for grocery retailers.
- Value
- ₹6.17 Cr
Skyways Air Services Acquisition Worth ₹3.13 Cr
Skyways Air Services will invest Rs.3.13 Crore in cash for additional equity in UAE subsidiary Skyways SLS Cargo Services LLC. The investment funds working capital needs.
- Value
- ₹3.13 Cr
- Execution
- Indicative completion within 30 days